GLP-1 drugs for diabetes may increase erectile dysfunction risk by 26% versus DPP-4 inhibitors Erectile dysfunction affects over half of men with diabetes due to vascular and nerve damage Biological links between GLP-1 drugs and sexual function remain unclear and need further study